 | Up a level |
McNair, Christopher; Xu, Kexin; Mandigo, Amy C; Benelli, Matteo; Leiby, Benjamin; Rodrigues, Daniel; Lindberg, Johan; Gronberg, Henrik; Crespo, Mateus; De Laere, Bram; Dirix, Luc; Visakorpi, Tapio; Li, Fugen; Feng, Felix Y; de Bono, Johann; Demichelis, Francesca; Rubin, Mark Andrew; Brown, Myles; Knudsen, Karen E (2018). Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of clinical investigation, 128(1), pp. 341-358. American Society for Clinical Investigation 10.1172/JCI93566
Luedeke, Manuel; Rinckleb, Antje E; FitzGerald, Liesel M; Geybels, Milan S; Schleutker, Johanna; Eeles, Rosalind A; Teixeira, Manuel R; Cannon-Albright, Lisa; Ostrander, Elaine A; Weikert, Steffen; Herkommer, Kathleen; Wahlfors, Tiina; Visakorpi, Tapio; Leinonen, Katri A; Tammela, Teuvo L J; Cooper, Colin S; Kote-Jarai, Zsofia; Edwards, Sandra; Goh, Chee L; McCarthy, Frank; ... (2016). Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Human molecular genetics, 25(24), pp. 5490-5499. Oxford University Press 10.1093/hmg/ddw349
Fleischmann, Achim; Saramäki, Outi R; Zlobec, Inti; Rotzer, Diana; Genitsch Gratwohl, Vera; Seiler, Roland; Visakorpi, Tapio; Thalmann, George (2014). Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers. Prostate, 74(16), pp. 1647-1654. Wiley-Blackwell 10.1002/pros.22882
Fleischmann, Achim; Seiler, Roland; Zlobec, Inti; Visakorpi, Tapio; Thalmann, George (April 2013). TMPRSS2-ERG Gene Fusion: Frequency and Prognostic Significance in Prostate Cancer Patients with Positive Lymph Nodes. Journal of urology, 189(4), E84-E85. Elsevier
